Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Electromed stock | $9.72

Own Electromed stock in just a few minutes.

Fact checked

Electromed, Inc is a medical devices business based in the US. Electromed shares (ELMD) are listed on the NYSE MKT and all prices are listed in US Dollars. Electromed employs 120 staff and has a trailing 12-month revenue of around USD$32.2 million.

How to buy shares in Electromed

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Electromed. Find the stock by name or ticker symbol: ELMD. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Electromed reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$9.72, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Electromed, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Electromed. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Electromed share price

Use our graph to track the performance of ELMD stocks over time.

Electromed shares at a glance

Information last updated 2020-12-27.
Latest market closeUSD$9.72
52-week rangeUSD$6.9157 - USD$18.7
50-day moving average USD$9.7948
200-day moving average USD$12.2806
Wall St. target priceUSD$17
PE ratio 24.3659
Dividend yield N/A (0%)
Earnings per share (TTM) USD$0.41

Buy Electromed shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
Stocks, Forex
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, ETFs
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stocks, Bonds
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Electromed stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Electromed price performance over time

Historical closes compared with the close of $9.72 from 2020-12-09

1 week (2021-01-12) -0.82%
1 month (2020-12-22) -3.38%
3 months (2020-10-20) 8.48%
6 months (2020-07-20) -40.88%
1 year (2020-01-18) N/A
2 years (2019-01-18) 94.40%
3 years (2018-01-19) 70.53%
5 years (2016-01-20) 471.76%

Is Electromed under- or over-valued?

Valuing Electromed stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Electromed's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Electromed's P/E ratio

Electromed's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Electromed shares trade at around 24x recent earnings.

Electromed's EBITDA

Electromed's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$4.2 million.

The EBITDA is a measure of a Electromed's overall financial performance and is widely used to measure a its profitability.

Electromed financials

Revenue TTM USD$32.2 million
Operating margin TTM 10.94%
Gross profit TTM USD$25.2 million
Return on assets TTM 6.8%
Return on equity TTM 12.74%
Profit margin 11.45%
Book value $3.585
Market capitalisation USD$86 million

TTM: trailing 12 months

Shorting Electromed shares

There are currently 228,221 Electromed shares held short by investors – that's known as Electromed's "short interest". This figure is 2.7% down from 234,511 last month.

There are a few different ways that this level of interest in shorting Electromed shares can be evaluated.

Electromed's "short interest ratio" (SIR)

Electromed's "short interest ratio" (SIR) is the quantity of Electromed shares currently shorted divided by the average quantity of Electromed shares traded daily (recently around 62185.558583106). Electromed's SIR currently stands at 3.67. In other words for every 100,000 Electromed shares traded daily on the market, roughly 3670 shares are currently held short.

However Electromed's short interest can also be evaluated against the total number of Electromed shares, or, against the total number of tradable Electromed shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Electromed's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Electromed shares in existence, roughly 30 shares are currently held short) or 0.032% of the tradable shares (for every 100,000 tradable Electromed shares, roughly 32 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Electromed.

Find out more about how you can short Electromed stock.

Electromed share dividends

We're not expecting Electromed to pay a dividend over the next 12 months.

Electromed share price volatility

Over the last 12 months, Electromed's shares have ranged in value from as little as $6.9157 up to $18.7. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Electromed's is 0.4609. This would suggest that Electromed's shares are less volatile than average (for this exchange).

Electromed overview

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of all ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site